BioCentury
ARTICLE | Financial News

Sequoia leads Cortexyme's $76M series B

June 1, 2018 8:03 PM UTC

Alzheimer’s disease company Cortexyme Inc. (South San Francisco, Calif.) raised $76 million in a series B round led by Sequoia Capital.

Fellow new investors included Vulcan Capital, Verily Life Sciences LLC (South San Francisco, Calif.), EPIQ Capital Group, RSL Investments, Huizenga Capital and an undisclosed long-term mutual fund. All of Cortexyme’s previous investors -- Pfizer Inc. (NYSE:PFE), Takeda Ventures, Lamond Family, Breakout Ventures and Dolby Family Ventures -- also participated...